Royal Bank of Canada’s Vigil Neuroscience VIGL Stock Holding History

Royal Bank of Canada’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,290	Closed	-$10K	–	7557
2025 Q2	$10K	Buy	+1,290	New	+$5.78K	﹤0.01%	6488
2024 Q4	–	Sell	-471	Closed	-$2K	–	7281
2024 Q3	$2K	Sell	471 -19,984	-98%	-$74K	﹤0.01%	6664
2024 Q2	$82K	Buy	20,455 +20,088	+5,474%	+$68.7K	﹤0.01%	5388
2024 Q1	$1K	Sell	367 -3,920	-91%	-$12.2K	﹤0.01%	6877
2023 Q4	$15K	Buy	4,287 +468	+12%	+$2.41K	﹤0.01%	6406
2023 Q3	$21K	Buy	3,819 +320	+9%	+$2.21K	﹤0.01%	6176
2023 Q2	$33K	Buy	+3,499	New	+$33.1K	﹤0.01%	5967
2022 Q4	–	Sell	-1,000	Closed	-$9K	–	7760
2022 Q3	$9K	Buy	+1,000	New	+$7.33K	﹤0.01%	6487
2022 Q2	–	Sell	-1,037	Closed	-$7K	–	7740
2022 Q1	$7K	Buy	+1,037	New	+$13.7K	﹤0.01%	7135

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Royal Bank of Canada's VIGL Position: Q3 2025 in Review

Royal Bank of Canada sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 1,290 shares — an estimated $10K sold.

Royal Bank of Canada first reported a position in VIGL in Q1 2022 and held it in 9 quarters. The position peaked at $82K in Q2 2024. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Royal Bank of Canada reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Royal Bank of Canada sold 1,290 Vigil Neuroscience shares in Q3 2025, an estimated $10K.
Royal Bank of Canada first reported a position in Vigil Neuroscience in Q1 2022 and held it in 9 quarters.
Royal Bank of Canada's Vigil Neuroscience position peaked at $82K in Q2 2024.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.